Muscle Relaxer Safety with Potassium Chloride Supplementation

Preferred Muscle Relaxants

For elderly patients or those with renal impairment, baclofen is the preferred choice, starting at 5 mg up to three times daily, with maximum tolerated doses of 30-40 mg per day 1
Tizanidine is an alternative option at 2 mg up to three times daily, though it requires monitoring for orthostatic hypotension and sedation, particularly in renally impaired patients 1

Cyclobenzaprine should be avoided in elderly patients due to its structural similarity to tricyclic antidepressants with comparable adverse effect profiles, including anticholinergic effects, CNS impairment, delirium, and increased fall risk 1
Carisoprodol should be avoided entirely due to high risk of sedation, falls, and significant potential for physical and psychological dependence 1
Orphenadrine should be avoided due to strong anticholinergic properties causing confusion, urinary retention, and cardiovascular instability, particularly problematic in elderly patients and those with cardiac issues 1

The American Geriatrics Society lists muscle relaxants as potentially inappropriate medications for older adults due to anticholinergic effects, sedation, and increased fall risk 1
Avoid co-prescribing muscle relaxants with opioids or benzodiazepines, as this combination increases mortality risk 3- to 10-fold 2
Assess the underlying reason for potassium supplementation, and choose baclofen as first-line for patients with renal impairment or cardiac disease 1
Start with the lowest effective dose and shortest duration necessary, and monitor for orthostatic hypotension, sedation, and fall risk 1